Eli Lilly and Company (LLY)
Interest coverage
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 4,962,800 | 6,096,400 | 7,191,400 | 8,123,700 | 7,040,500 | 6,573,900 | 7,669,100 | 6,632,000 | 7,138,000 | 6,878,900 | 6,560,800 | 7,069,500 | 6,495,200 | 7,132,200 | 7,330,100 | 7,381,300 | 7,589,500 | 6,790,200 | 6,776,600 | 6,621,400 |
Interest expense (ttm) | US$ in thousands | 179,600 | 317,800 | 442,400 | 562,700 | 485,900 | 431,700 | 388,600 | 349,500 | 331,600 | 329,000 | 331,100 | 336,800 | 339,700 | 347,500 | 353,500 | 354,900 | 359,600 | 366,300 | 384,100 | 406,700 |
Interest coverage | 27.63 | 19.18 | 16.26 | 14.44 | 14.49 | 15.23 | 19.74 | 18.98 | 21.53 | 20.91 | 19.82 | 20.99 | 19.12 | 20.52 | 20.74 | 20.80 | 21.11 | 18.54 | 17.64 | 16.28 |
December 31, 2024 calculation
Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $4,962,800K ÷ $179,600K
= 27.63
The interest coverage ratio of Eli Lilly and Company has been relatively healthy and stable over the past few years based on the provided data. The ratio indicates the company's ability to meet its interest obligations from its earnings before interest and taxes (EBIT).
From March 31, 2020, to December 31, 2024, the interest coverage ratio has fluctuated within a range between approximately 14.44 to 27.63. This range generally suggests that Eli Lilly has sufficient earnings to cover its interest expenses comfortably.
The highest interest coverage ratio was observed on December 31, 2024, at 27.63, indicating a strong ability to meet interest payments. However, there was a decrease in the ratio in the following quarters, reaching a low of 14.49 on December 31, 2023. This drop may signal a potential challenge in meeting interest obligations from earnings, although the ratio improved in subsequent periods.
Overall, Eli Lilly and Company's interest coverage ratios demonstrate a consistent ability to cover interest expenses with its operating income, reflecting financial stability and management's effective handling of debt obligations.
Peer comparison
Dec 31, 2024